NSE: SYNGENE · 27 October 2026
- Syngene International Ltd. shares advanced 1.32% on Monday, trading between an intraday low of ₹358.75 and a high of ₹367.0 before settling at ₹364.6.
- Syngene International Limited informed the exchanges that a meeting of the Board of Directors is scheduled for October 27, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ending September 30, 2026. This precedes the upcoming earnings disclosures and earnings call preparations.
- Trading volume was 0.95 times the 20-day average daily volume.
Why is Syngene International share price rising on 27 October 2026?
Syngene International Ltd. shares advanced 1.32% on Monday, trading between an intraday low of ₹358.75 and a high of ₹367.0 before settling at ₹364.6.
The stock's upward movement outpaced the broader benchmark Nifty, which dipped marginally by 0.02%, and broadly mirrored strength within its sector. The Nifty Pharma index outperformed with a notable gain of 2.06%, highlighting strong sector-wide buying interest in pharmaceutical counters. Despite today's uptick, the stock has experienced recent pressure, registering a 5-day return of -8.28% and a 20-day return of -3.72%.
Company developments indicate ongoing preparation for upcoming earnings announcements, with the board meeting scheduled for October 27, 2026, to review financial results for the quarter and half year ending September 30, 2026. While no immediate same-day operational catalyst was disclosed, the positive price action aligns with broader sector momentum and represents a modest recovery following recent downward pressure.
6.84 lakh shares traded by 27 October 2026 · 02:55 PM IST. This compares with a 20-day average daily volume of 7.22 lakh shares (0.95 times). The five-day average daily volume was 8.42 lakh shares. Separately, the NSE report for 26 October 2026 showed 6.65 lakh shares delivered, representing 63.89% of that day’s traded volume. The same report recorded 45,578 trades.
The upward price move appears consistent with broader sector strength in pharmaceutical stocks and a technical recovery from recent losses, as no direct same-day catalyst was announced.
Latest Company Developments
Syngene International Limited informed the exchanges that a meeting of the Board of Directors is scheduled for October 27, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ending September 30, 2026. This precedes the upcoming earnings disclosures and earnings call preparations.
Upcoming financial results announcements frequently drive heightened investor attention and positioning as market participants anticipate performance updates.
Mr. Pramuch Goel resigned from his position as Head of Corporate Affairs & Communications and member of the Executive Committee effective from the close of business hours on September 21, 2026, to pursue other career opportunities. The company duly submitted the required regulatory disclosures regarding the cessation.
Leadership and senior management transitions are important for tracking organizational continuity and corporate communications governance.
a press release dated July 29, 2026, titled "Q1 FY27 revenue from operations at Rs. 736 Cr; Operating EBITDA at Rs. 91 Cr".
Resignation of Mr. Pramuch Goel as Head Corporate Affairs & Communications and a member of Executive Committee (Senior Management Personnel) of the company effective. close of business hours of September 21, 2026.
the Communication regarding remittance of final dividend for the FY 2025-26.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 27.10% on 30 September 2026. This compares with 25.78% on 30 June 2026, a change of +1.32 percentage points.
The filing reported 28 MF/UTI holders.
Historical Bulk / Block Deals
What to Watch Next
- Upcoming financial results for the quarter and half year ended September 30, 2026
- Management commentary on contract research and manufacturing services (CRAMS) demand growth
- Delivery percentage trends relative to the 63.89% recorded in the previous trading day
- Performance relative to the Nifty Pharma sector benchmark
More Syngene International news and dated analysis →
Frequently Asked Questions
What is the latest Syngene International company news?
Syngene International Limited informed the exchanges that a meeting of the Board of Directors is scheduled for October 27, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ending September 30, 2026. This precedes the upcoming earnings disclosures and earnings call preparations.
How strong was Syngene International’s trading volume?
6.84 lakh shares traded, 0.95 times the 20-day average daily volume. The price and volume data are dated 27 October 2026 · 02:55 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.